PYMNTS.com January 15, 2024

Apple has reportedly made a strategic move to avoid a U.S. ban on some of its smartwatches.

Facing a ban resulting from a patent dispute with global medical technology firm Masimo, Apple has decided to remove a blood oxygen feature from its Series 9 and Ultra 2 smartwatches, Bloomberg reported Monday (Jan. 15), citing a disclosure by Masimo.

Apple did not immediately reply to PYMNTS’ request for comment.

The U.S. Customs and Border Protection approved this change on Friday (Jan. 12), stating that the redesigned smartwatches fall outside the scope of the import ban imposed by the U.S. International Trade Commission (ITC), according to the report.

The potential ban of the products began when the ITC ruled in October that...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Technology, Wearables
Wearable Health Tech: Innovations and Impacts on Chronic Disease Management
Driving Urgent Change To Optimize The Patient Experience
Sibionics Blood Glucose Sensor: Review
Dexcom invests $75M in Ōura, agrees to integrate smart rings and CGMs
Wearable Device Can Warn of Worsening Heart Failure

Share This Article